Michel Janicot R
Biochemistry
ITRI International Center
Belgium
Biography
Dr. Michel Janicot holds a Ph.D. degree in Biochemistry (Molecular and Cellular Biology) from the University of Paris VII (France) after which he was Postdoctoral Fellow at The Johns Hopkins University (Baltimore, MD. USA). Michel has over 25 years hands-on experience in Oncology R&D and specially in preclinical and early clinical pharmaceutical drug development in increasing leadership roles at Rhone-Poulenc Rorer (Sanofi) and subsequentlt at Janssen (Johnson & Johnson). Since 2012, Michel is the founder and Managing Director of JMi ONConsulting, a firm specialized in providing consulting services and guidances for R&D programs in the field of Oncology, Inflammation, Immunology, Fibrosis and Ophthalmology. Under this umbrella, Michel is a part-time management team member at Isarna Therapeutics GmbH and InteRNA Technologies NV. He is also co-founder and Board member of aPODD, a non-profit foundation focusing on Pediatric Oncology Drug Development, and acting Chief Scientific Officer at OncoKids BioSciences. Michel joined ITeos Therapeutics as Senior Scientific Advisor in 2017
Research Interest
Biochemistry (Molecular and Cellular Biology)
